|
|
Volumn 13, Issue 2, 2003, Pages 223-231
|
|
Pharmacia Corp.: Analysis of patenting 1998 - 2002
a
|
|
Author keywords
Company profile; Inc.; Patenting activity; Pfizer; Pharmacia Corp.; Research trends
|
|
Indexed keywords
CELECOXIB;
CISPLATIN;
CYCLOOXYGENASE 2 INHIBITOR;
EPLERENONE;
EXEMESTANE;
FLUOXETINE;
FORASARTAN;
IGMESINE;
METALLOPROTEINASE INHIBITOR;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;
NITRIC OXIDE SYNTHASE INHIBITOR;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE;
PROTEIN TYROSINE KINASE INHIBITOR;
SAFINGOL;
SEROTONIN UPTAKE INHIBITOR;
SIGMA RECEPTOR LIGAND;
SOMATOMEDIN B;
SPHINGOLIPID;
VALDECOXIB;
ANALYTIC METHOD;
ARTHRITIS;
ARTICLE;
CANCER;
CONTROLLED STUDY;
DATA ANALYSIS;
DATA BASE;
DEPRESSION;
DRUG INDUSTRY;
EUROPE;
HEAD INJURY;
HEALTH CARE ORGANIZATION;
INFLAMMATION;
MEDICAL RESEARCH;
MELANOMA;
METHODOLOGY;
PATENT;
PSORIASIS;
PUBLICATION;
RESTENOSIS;
STROKE;
|
|
EID: 0037315585
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.13.2.223 Document Type: Article |
|
Times cited : (1)
|
|
References (2)
|
